Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(80.0%)

Phase 4

1(10.0%)

Phase 3

1(10.0%)

10Total

N/A(8)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07531576Not ApplicableCompleted

Outcome of Primary vs Delayed Primary Closure of Laparotomy in Dirty Abdominal Wounds

Role: lead

NCT05602688Not ApplicableCompleted

Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance

Role: lead

NCT05480670Not ApplicableCompleted

Treatment Benefits of Berberine Supplementation for Women With PCOS

Role: lead

NCT05679102Not ApplicableCompleted

Atorvastatin as an Antihypertensive Agent

Role: collaborator

NCT04667780Phase 3Completed

Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19

Role: lead

NCT05467384Phase 4Completed

Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients

Role: lead

NCT05467618Not ApplicableCompleted

Comparison of Surgical Approaches in Reducing Mandibular Angle Fracture

Role: lead

NCT05405335Not ApplicableCompleted

Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome.

Role: collaborator

NCT05008003Not ApplicableUnknown

Vit D3 for Early Symptoms of COVID-19

Role: lead

NCT04785404Not ApplicableCompleted

Primary Versus Secondary Closure of Stoma-Reversal Skin Wound

Role: lead

All 10 trials loaded